Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 45 studies | 43% ± 19% | |
macrophage | 26 studies | 36% ± 21% | |
fibroblast | 25 studies | 34% ± 17% | |
pericyte | 20 studies | 31% ± 16% | |
astrocyte | 20 studies | 64% ± 19% | |
oligodendrocyte precursor cell | 17 studies | 49% ± 20% | |
microglial cell | 17 studies | 57% ± 19% | |
oligodendrocyte | 16 studies | 65% ± 16% | |
mast cell | 15 studies | 29% ± 11% | |
smooth muscle cell | 15 studies | 33% ± 14% | |
ciliated cell | 14 studies | 32% ± 13% | |
classical monocyte | 14 studies | 25% ± 10% | |
endothelial cell of lymphatic vessel | 13 studies | 38% ± 18% | |
basal cell | 13 studies | 36% ± 21% | |
glutamatergic neuron | 13 studies | 48% ± 23% | |
capillary endothelial cell | 12 studies | 29% ± 13% | |
GABAergic neuron | 11 studies | 51% ± 21% | |
endothelial cell of artery | 11 studies | 30% ± 13% | |
epithelial cell | 11 studies | 44% ± 23% | |
plasmacytoid dendritic cell | 11 studies | 22% ± 7% | |
myeloid cell | 11 studies | 36% ± 12% | |
vein endothelial cell | 10 studies | 35% ± 19% | |
adipocyte | 10 studies | 37% ± 15% | |
monocyte | 9 studies | 40% ± 18% | |
neuron | 9 studies | 47% ± 26% | |
type I pneumocyte | 8 studies | 36% ± 14% | |
type II pneumocyte | 8 studies | 38% ± 16% | |
connective tissue cell | 8 studies | 29% ± 9% | |
myofibroblast cell | 8 studies | 28% ± 15% | |
amacrine cell | 8 studies | 45% ± 15% | |
retinal rod cell | 8 studies | 58% ± 23% | |
B cell | 7 studies | 23% ± 6% | |
interneuron | 7 studies | 60% ± 19% | |
club cell | 7 studies | 41% ± 16% | |
retinal cone cell | 7 studies | 64% ± 22% | |
dendritic cell | 7 studies | 46% ± 11% | |
endothelial cell of vascular tree | 7 studies | 33% ± 22% | |
respiratory goblet cell | 6 studies | 44% ± 22% | |
CD16-negative, CD56-bright natural killer cell, human | 6 studies | 23% ± 4% | |
conventional dendritic cell | 6 studies | 27% ± 17% | |
retina horizontal cell | 6 studies | 46% ± 24% | |
Mueller cell | 6 studies | 59% ± 26% | |
natural killer cell | 5 studies | 23% ± 3% | |
secretory cell | 5 studies | 27% ± 5% | |
retinal bipolar neuron | 5 studies | 35% ± 22% | |
glial cell | 5 studies | 39% ± 18% | |
retinal ganglion cell | 5 studies | 40% ± 20% | |
brush cell | 5 studies | 33% ± 7% | |
cardiac muscle cell | 5 studies | 46% ± 13% | |
mesothelial cell | 5 studies | 41% ± 18% | |
neutrophil | 5 studies | 24% ± 8% | |
goblet cell | 5 studies | 38% ± 24% | |
squamous epithelial cell | 4 studies | 38% ± 22% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 21% ± 6% | |
podocyte | 4 studies | 42% ± 17% | |
progenitor cell | 4 studies | 50% ± 26% | |
abnormal cell | 4 studies | 34% ± 17% | |
granule cell | 4 studies | 52% ± 7% | |
retinal pigment epithelial cell | 4 studies | 49% ± 27% | |
enteroendocrine cell | 4 studies | 32% ± 12% | |
alveolar macrophage | 4 studies | 46% ± 19% | |
ionocyte | 3 studies | 36% ± 8% | |
cholangiocyte | 3 studies | 46% ± 21% | |
non-classical monocyte | 3 studies | 28% ± 4% | |
glomerular endothelial cell | 3 studies | 22% ± 3% | |
renal beta-intercalated cell | 3 studies | 48% ± 19% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 57% ± 3% | |
GABAergic interneuron | 3 studies | 47% ± 12% | |
precursor B cell | 3 studies | 19% ± 2% | |
plasma cell | 3 studies | 29% ± 6% | |
endocardial cell | 3 studies | 37% ± 11% | |
mononuclear phagocyte | 3 studies | 41% ± 4% | |
lymphocyte | 3 studies | 30% ± 4% | |
GABAergic amacrine cell | 3 studies | 57% ± 15% | |
OFF-bipolar cell | 3 studies | 56% ± 26% | |
ON-bipolar cell | 3 studies | 41% ± 17% | |
glycinergic amacrine cell | 3 studies | 48% ± 11% | |
rod bipolar cell | 3 studies | 36% ± 21% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 20% ± 4% | |
hepatocyte | 3 studies | 63% ± 14% | |
neural progenitor cell | 3 studies | 66% ± 22% | |
ependymal cell | 3 studies | 60% ± 8% | |
T cell | 3 studies | 30% ± 10% | |
chondrocyte | 3 studies | 38% ± 16% | |
renal principal cell | 3 studies | 45% ± 21% | |
mucus secreting cell | 3 studies | 54% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 51% ± 21% | |
lung | 11 studies | 32% ± 10% | |
eye | 9 studies | 52% ± 23% | |
intestine | 6 studies | 23% ± 10% | |
heart | 5 studies | 39% ± 13% | |
kidney | 4 studies | 38% ± 14% | |
peripheral blood | 3 studies | 33% ± 10% | |
liver | 3 studies | 40% ± 18% | |
adipose | 3 studies | 41% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2984.10 | 1445 / 1445 | 100% | 9.10 | 183 / 183 |
brain | 100% | 2656.54 | 2640 / 2642 | 99% | 9.00 | 696 / 705 |
thymus | 100% | 3859.41 | 653 / 653 | 98% | 9.75 | 594 / 605 |
prostate | 100% | 2968.13 | 245 / 245 | 97% | 6.00 | 488 / 502 |
lung | 100% | 3156.57 | 578 / 578 | 97% | 6.15 | 1120 / 1155 |
pancreas | 99% | 1900.61 | 326 / 328 | 96% | 6.38 | 171 / 178 |
breast | 100% | 3136.71 | 459 / 459 | 95% | 7.25 | 1062 / 1118 |
stomach | 100% | 2163.72 | 359 / 359 | 94% | 5.69 | 268 / 286 |
adrenal gland | 100% | 3449.10 | 258 / 258 | 93% | 5.65 | 215 / 230 |
intestine | 100% | 3080.45 | 966 / 966 | 92% | 5.35 | 484 / 527 |
ovary | 100% | 4694.14 | 180 / 180 | 90% | 4.89 | 385 / 430 |
uterus | 100% | 4029.21 | 170 / 170 | 89% | 4.64 | 409 / 459 |
bladder | 100% | 2905.57 | 21 / 21 | 87% | 4.79 | 436 / 504 |
kidney | 100% | 1908.92 | 89 / 89 | 86% | 4.97 | 773 / 901 |
skin | 100% | 2253.76 | 1807 / 1809 | 77% | 4.11 | 365 / 472 |
liver | 99% | 1140.94 | 223 / 226 | 40% | 1.58 | 164 / 406 |
blood vessel | 100% | 2458.64 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 2314.49 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2860.61 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1819.65 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1538.25 | 852 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1512.40 | 834 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 78% | 4.56 | 35 / 45 |
eye | 0% | 0 | 0 / 0 | 48% | 2.25 | 38 / 80 |
lymph node | 0% | 0 | 0 / 0 | 38% | 1.32 | 11 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | BAZ2B |
Protein name | Uncharacterized protein BAZ2B BAZ2B protein Bromodomain adjacent to zinc finger domain 2B Alternative protein BAZ2B Bromodomain adjacent to zinc finger domain protein 2B (hWALp4) |
Synonyms | KIAA1476 |
Description | FUNCTION: Regulatory subunit of the ATP-dependent BRF-1 and BRF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair . Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template . The BRF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the BRF-5 ISWI chromatin remodeling complex . Chromatin reader protein, which may play a role in transcriptional regulation via interaction with ISWI (By similarity) . Involved in positively modulating the rate of age-related behavioral deterioration (By similarity). Represses the expression of mitochondrial function-related genes, perhaps by occupying their promoter regions, working in concert with histone methyltransferase EHMT1 (By similarity). . |
Accessions | L8EAN3 ENST00000541068.6 ENST00000392783.7 [Q9UIF8-1] H7BXK5 ENST00000392782.5 [Q9UIF8-5] H7C092 ENST00000441143.1 ENST00000437839.5 Q9UIF8 H7C1I6 ENST00000294905.4 Q53TG3 F6VJC3 ENST00000426648.1 Q3B7K5 C9JCA6 |